Table 1.
Characteristic | N = 34 |
---|---|
Sex | |
Male | 17 |
Female | 17 |
Age (y) | |
Median | 60.5 |
Range | 36–77 |
Race | |
White | 30 |
Black | 1 |
Hispanic | 1 |
Unknown | 2 |
Histotype | |
Adenocarcinoma | 15 |
Squamous cell carcinoma | 3 |
Adenosquamous cell carcinoma | 7 |
Large cell carcinoma | 5 |
Not otherwise specified | 3 |
EGFR mutation | |
Positive | 3 |
Negative | 17 |
Unknown | 14 |
ALK fusion | |
Positive | 2 |
Negative | 12 |
Unknown | 20 |
Smoking status | |
Current | 12 |
Former | 18 |
Never | 1 |
Unknown | 3 |
Interval between lung and brain tumor sampling (d) | |
Median | 335.5 |
Range | 0–2618 |
Clinical stage at the time of lung tumor sampling | |
Nonmetastatic | 23 |
Metastatic | 9 |
Unknown | 2 |